Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 10,393-10,404 of 10,661

Drug study icon

CompletedNCT01378858

Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: Albert Einstein College of Medicine
Condition: Addiction

Drug study icon

CompletedNCT02892110

Varenicline Treatment for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Addiction

Drug study icon

CompletedNCT01010204

Varenicline Treatment for Smoking Cessation in people with Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: K.N. Roy Chengappa
Condition: Bipolarity

Drug study icon

CompletedNCT00727103

Varenicline Treatment in Alcohol and Nicotine Dependent people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Schizophrenia, AddictionDrugFrom 18 Years to 69 Years

Countries: United States
Sponsor: State University of New York - Upstate Medical University
Condition: Schizophrenia, Addiction

Drug study icon

CompletedNCT01011829

Varenicline vs Placebo for Methamphetamine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugOver 18 Years

Countries: United States
Sponsor: University of California, Los Angeles
Condition: Addiction

Drug study icon

CompletedNCT01308736

Varenicline-Aided Cigarette Reduction in Smokers Not Ready to Quit

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Rutgers, The State University of New Jersey
Condition: Addiction

Behavioral study icon

CompletedNCT02313818

Variable-length Cognitive Processing Therapy for Combat-Related PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: Duke University
Condition: PTSD

Other study type icon

CompletedNCT01107301

Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDObservationalFrom 6 Years to 18 Years

Countries: United States
Sponsor: University of Minnesota
Condition: ADHD

Other study type icon

CompletedNCT02257216

Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDOtherFrom 18 Years to 60 Years

Countries: United States
Sponsor: Enzymotec
Condition: ADHD

Behavioral study icon

CompletedNCT02823457

VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C

This study is completed in the United States. It focuses on Addiction.

In United States

AddictionBehavioralFrom 18 Years to 90 Years

Countries: United States
Sponsor: G.V. (Sonny) Montgomery VA Medical Center
Condition: Addiction

Other study type icon

CompletedNCT00105274

Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 18 Years to 50 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Schizophrenia

Drug study icon

CompletedNCT00249483

Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.